BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 117998
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.117998
Figure 2
Figure 2 Endoscopic and gross pathological evidence of differential mucosal healing post-tofacitinib therapy. A: Follow-up colonoscopy illustrating a heterogeneous healing pattern: Mucosal remission in the right colon (Mayo Endoscopic Score 0-1) contrasted with persistent severe inflammation in the distal segments, including the rectum and sigmoid colon (Mayo Endoscopic Score 3); B: Gross specimen of the resected colorectum demonstrating severe inflammation, mural thickening, and extensive ulceration in the sigmoid colon and rectum, confirming the extent of medically refractory disease.


Write to the Help Desk